These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22980057)

  • 1. Inotropic therapy: an important role in the treatment of advanced symptomatic heart failure.
    McCann P; Hauptman PJ
    Med Clin North Am; 2012 Sep; 96(5):943-54. PubMed ID: 22980057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical therapy and prognosis in chronic heart failure. Lessons from clinical trials.
    Ramahi TM; Lee FA
    Cardiol Clin; 1995 Feb; 13(1):5-26. PubMed ID: 7796432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolving concepts in the treatment of heart failure: should new inotropic agents carry promise or paranoia?
    Young JB
    Pharmacotherapy; 1996; 16(2 Pt 2):78S-84S. PubMed ID: 8668609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current approaches to intraoperative diagnosis and treatment of low cardiac output during cardiosurgical operations].
    Iavorovskiĭ AG; Flerov EV; Sandrikov VA; Buniatian AA
    Anesteziol Reanimatol; 2006; (5):5-10. PubMed ID: 17184052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited role for ivabradine in the treatment of chronic heart failure.
    Cullington D; Goode KM; Cleland JG; Clark AL
    Heart; 2011 Dec; 97(23):1961-6. PubMed ID: 21917660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overview of inotropic agents.
    Vroom MB
    Semin Cardiothorac Vasc Anesth; 2006 Sep; 10(3):246-52. PubMed ID: 16959760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
    Follath F
    Ital Heart J; 2003 May; 4 Suppl 2():34S-38S. PubMed ID: 14635368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience of a new inotropic agent--Prenalterol--in hypotension and heart failure.
    Reiz S; Waagstein F; Hjalmarson A
    Clin Cardiol; 1980 Apr; 3(2):96-105. PubMed ID: 6104553
    [No Abstract]   [Full Text] [Related]  

  • 9. Vasodilators and inotropic agents in the treatment of congestive heart failure.
    Francis GS
    Semin Nephrol; 1994 Sep; 14(5):464-78. PubMed ID: 7997651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic management of heart failure among older adults by office-based physicians in the United States.
    Croft JB; Giles WH; Roegner RH; Anda RF; Casper ML; Livengood JR
    J Fam Pract; 1997 Apr; 44(4):382-90. PubMed ID: 9108836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guideline for the management of heart failure caused by systolic dysfunction: part II. Treatment.
    Chavey WE; Blaum CS; Bleske BE; Harrison RV; Kesterson S; Nicklas JM;
    Am Fam Physician; 2001 Sep; 64(6):1045-54. PubMed ID: 11578026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New positive inotropic agents in the treatment of left ventricular dysfunction.
    De Luca L; Proietti P; Palombaro GL; Battagliese A; Celotto A; Bucciarelli Ducci C; Fedele F
    Ital Heart J; 2004 Jun; 5 Suppl 6():63S-67S. PubMed ID: 15185917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of levosimendan on right ventricular function in patients with advanced heart failure.
    Parissis JT; Paraskevaidis I; Bistola V; Farmakis D; Panou F; Kourea K; Nikolaou M; Filippatos G; Kremastinos D
    Am J Cardiol; 2006 Dec; 98(11):1489-92. PubMed ID: 17126656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A promising new inotrope: levosimendan.
    Fotbolcu H; Duman D
    Anadolu Kardiyol Derg; 2010 Apr; 10(2):176-82. PubMed ID: 20382619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction--pharmacological approaches. Heart Failure Society of America.
    Pharmacotherapy; 2000 May; 20(5):495-522. PubMed ID: 10809338
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacologic support for postoperative low cardiac output.
    DiSesa VJ
    Semin Thorac Cardiovasc Surg; 1991 Jan; 3(1):13-23. PubMed ID: 2015312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inotropic treatment in heart transplantation].
    Giordano F; Muzzi R
    Minerva Anestesiol; 1992 Oct; 58(10):657-64. PubMed ID: 1461438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of heart failure with abnormal left ventricular systolic function in the elderly.
    Aronow WS
    Clin Geriatr Med; 2007 Feb; 23(1):61-81. PubMed ID: 17126755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hawthorn extract WS 1442 in the treatment of patients with heart failure and LVEF of 25%-35%].
    Von Holubarsch CJ; Niestroj M; Wassmer A; Gaus W; Meinertz T
    MMW Fortschr Med; 2010 Jul; 152 Suppl 2():56-61. PubMed ID: 21591320
    [No Abstract]   [Full Text] [Related]  

  • 20. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure).
    Stevenson LW; Miller LW; Desvigne-Nickens P; Ascheim DD; Parides MK; Renlund DG; Oren RM; Krueger SK; Costanzo MR; Wann LS; Levitan RG; Mancini D;
    Circulation; 2004 Aug; 110(8):975-81. PubMed ID: 15313942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.